Evidence map›Paper›PMID 25960942›Full record

ReviewCurrent tropical medicine reports

Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy.

David Meya, Radha Rajasingham, Elizabeth Nalintya, Mark Tenforde, Joseph N Jarvis

Open access · hybridAbstract readReview
In one paragraph

Review in Current tropical medicine reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. OccultOpen forum infectious diseases · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Longitudinal Changes in Cd4Journal of fungi (Basel, Switzerland) · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Cryptococcal meningitis: A neglected NTD?PLoS neglected tropical diseases · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

David MeyaInfectious Disease Institute, College of Health Sciences, Makerere University, Mulago Hill Road, # 22418, Kampala, Uganda ; Department of Medicine, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, 450 Delaware Street, MMC250, Minneapolis, MN 55455 USA ; School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Radha RajasinghamDepartment of Medicine, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, 450 Delaware Street, MMC250, Minneapolis, MN 55455 USA.
Elizabeth NalintyaInfectious Disease Institute, College of Health Sciences, Makerere University, Mulago Hill Road, # 22418, Kampala, Uganda.
Mark TenfordeBotswana-UPenn Partnership, P.O. Box AC 157 ACH, Gaborone, Botswana.
Joseph N JarvisBotswana-UPenn Partnership, P.O. Box AC 157 ACH, Gaborone, Botswana ; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA ; London School of Hygiene and Tropical Medicine, London, UK.
Botswana Open University · BWMakerere University · UGUniversity of Minnesota Medical Center · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
Trial for the Optimal Timing of HIV Therapy after Cryptococcal MeningitisU01AI089244 · NIAID · UNIVERSITY OF MINNESOTA · PI BOULWARE, DAVID R · 2010 to 2014
$7.6M
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responsesR01AI108479 · NIAID · UNIVERSITY OF COLORADO DENVER · PI JANOFF, EDWARD N · 2014 to 2018
$2.3M
The immunopathogenesis of HIV-related Immune Reconstitution Inflammatory SyndromeR01AI078934 · NIAID · INFECTIOUS DISEASES INSTITUTE · PI KAMBUGU, ANDREW DDUNGU, MEYA, DAVID BISAGAYA · 2010 to 2013
$415k
CGH CDC HHS U01 GH000517NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI078934NIAID NIH HHS R01 AI108479NIAID NIH HHS U01 AI089244Wellcome Trust 087540
6 · The paper itself

Abstract

Cryptococcosis remains a significant cause of morbidity and mortality among HIV-infected patients, especially in sub-Saharan Africa where it causes up to 20 % of AIDS-related deaths in HIV programs. A new, highly sensitive, and affordable point of care diagnostic test for cryptococcal infection, the lateral flow assay, can detect early sub-clinical cryptococcosis especially in areas with limited laboratory infrastructure. With a prevalence of detectable sub-clinical cryptococcal infection averaging 7.2 % (95 % CI 6.8-7.6 %) among 36 cohorts with CD4 <100 cells/μL in Africa, together with data showing that preemptive fluconazole prevents overt cryptococcal disease in this population, implementing a screen and treat strategy as part of HIV care practice among patients with CD4 <100 cells/μL could prevent the incidence of often fatal cryptococcal meningitis in the setting of the HIV pandemic.

Indexed as

CD4CRAG screeningCryptococcal antigenCryptococcosisFluconazoleHIVPreemptive therapy

Identifiers

PMID25960942
PMCPMC4412515
OpenAlexW2049532563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.